Superintensive chemotherapy and autologous bone-marrow transplantation in non-Hodgkin's lymphoma

Environmental and occupational factors in the aetiopathogenesis of systemic sclerosis: insights from a large multinational patient survey.

Scandinavian journal of rheumatology·2026

The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review.

Respiratory research·2024

Alcohol use and abuse: a cross-sectional study among Italian adolescents.

Journal of preventive medicine and hygiene·2018

MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine.

The pharmacogenomics journal·2017

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia.

Leukemia·2017

Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice.

Eye (London, England)·2017

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Lactate Homeostasis Disruption Potentiates TACE-Immunotherapy in Hepatocellular Carcinoma.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

DUMP Cascade-Oriented MnOx@MSN Nanoadjuvant for Subunit Vaccine Antigen Delivery and Immune Potentiation.

ACS applied bio materials·2026

Effect of Multidimensional Discharge Preparation Based on Meleis' Transition Theory in Patients After Laryngeal Cancer Surgery: A Prospective Randomized Controlled Study.

Quality management in health care·2026

Electroconvulsive Therapy and the Long-Term Risk of Dementia: Conceptual Issues, Methodological Issues, and Recent Findings.

The Journal of clinical psychiatry·2026

Venetoclax as Salvage Treatment for Relapsed/Refractory B-ALL Post-CAR-T Therapy.

Pediatric blood & cancer·2026

Mitochondrial Reprogramming Along the Gut-Brain Axis in Chemotherapy-Induced Cognitive Impairment: A Narrative Review.

Oxidative medicine and cellular longevity·2026

Related Experiment Videos

Superintensive chemotherapy and autologous bone-marrow transplantation in non-Hodgkin's lymphoma

Related Concept Videos

Environmental and occupational factors in the aetiopathogenesis of systemic sclerosis: insights from a large multinational patient survey.

The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review.

Alcohol use and abuse: a cross-sectional study among Italian adolescents.

MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine.

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia.

Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lactate Homeostasis Disruption Potentiates TACE-Immunotherapy in Hepatocellular Carcinoma.

DUMP Cascade-Oriented MnOx@MSN Nanoadjuvant for Subunit Vaccine Antigen Delivery and Immune Potentiation.

Effect of Multidimensional Discharge Preparation Based on Meleis' Transition Theory in Patients After Laryngeal Cancer Surgery: A Prospective Randomized Controlled Study.

Electroconvulsive Therapy and the Long-Term Risk of Dementia: Conceptual Issues, Methodological Issues, and Recent Findings.

Venetoclax as Salvage Treatment for Relapsed/Refractory B-ALL Post-CAR-T Therapy.

Mitochondrial Reprogramming Along the Gut-Brain Axis in Chemotherapy-Induced Cognitive Impairment: A Narrative Review.

Related Experiment Videos

Superintensive chemotherapy and autologous bone-marrow transplantation in non-Hodgkin's lymphoma

Related Concept Videos

Related Articles